Filtered By:
Source: Clinical and Experimental Nephrology

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 23 results found since Jan 2013.

Low serum phosphate is associated with ischemic stroke in hemodialysis patients
ConclusionsLow serum phosphate is a risk factor for developing ischemic stroke in hemodialysis patients. The results suggest that managing serum phosphate  ≥ 4.5 mg/dL among hemodialysis patients may reduce the risk of ischemic stroke.
Source: Clinical and Experimental Nephrology - April 20, 2018 Category: Urology & Nephrology Source Type: research

N-terminal pro-brain natriuretic peptide predicts hospitalization for ischemic stroke in Japanese hemodialysis patients
ConclusionsElevated NT-proBNP level was associated with hospitalization for ischemic stroke, suggesting that NT-proBNP level is a valid biomarker for predicting hospitalization for ischemic stroke in HD outpatients.
Source: Clinical and Experimental Nephrology - July 15, 2022 Category: Urology & Nephrology Source Type: research

Impact of atrial fibrillation on the risk of ischemic stroke in patients on hemodialysis: BOREAS-HD3 Study
ConclusionPresent analyses using comprehensive adjustment for multiple confounders, including prior history of ischemic stroke, indicated that AF independently increases the risk of new-onset of ischemic stroke by more than twofold in Japanese HD patients.
Source: Clinical and Experimental Nephrology - November 18, 2020 Category: Urology & Nephrology Source Type: research

Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study
Conclusions This study has shown that serum uric acid is independently associated with the incidence of nonfatal stroke in the general Japanese population.
Source: Clinical and Experimental Nephrology - July 11, 2016 Category: Urology & Nephrology Source Type: research

Prognostic factors for acute ischemic stroke in patients undergoing hemodialysis
ConclusionsAlong with neurological severity, dialysis vintage, intradialytic hypotension, and diabetic nephropathy could worsen the prognosis of patients with AIS undergoing hemodialysis.
Source: Clinical and Experimental Nephrology - November 12, 2021 Category: Urology & Nephrology Source Type: research

Effect of renin –angiotensin system blockade on graft survival and cardiovascular disease in kidney transplant recipients: retrospective multicenter study in Japan
ConclusionThus, RASBs potentially reduce stroke events in KT recipients.
Source: Clinical and Experimental Nephrology - December 25, 2019 Category: Urology & Nephrology Source Type: research

Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective
ConclusionsThe prevalence of CVD is high among patients with ADPKD, and the most important risk factor associated with CVD is severity of RD. We found an increase in the trend of hospitalizations of patients with ADPKD associated with increased risk of AF, PHN, NICM, and hemorrhagic stroke. History of CVD is the strongest predictor of mortality among patients with ADPKD.
Source: Clinical and Experimental Nephrology - February 25, 2022 Category: Urology & Nephrology Source Type: research

Prediction of cardiovascular outcome by estimated glomerular filtration rate among high-risk patients: a Thai nationwide cohort study
ConclusionLower baseline kidney function was independently associated with increased risk of CV events and all-cause mortality in Thai populations at high CV risk.
Source: Clinical and Experimental Nephrology - August 23, 2022 Category: Urology & Nephrology Source Type: research

Neutrophil gelatinase-associated lipocalin levels associated with cardiovascular disease in chronic kidney disease patients
Conclusion These findings suggest that NGAL levels can be used to detect the prevalence of CVD in HD patients with or without diabetes.
Source: Clinical and Experimental Nephrology - October 1, 2014 Category: Urology & Nephrology Source Type: research

Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD
Conclusions Urinary L-FABP may be a useful prognostic marker of progression to ESRD and the onset of CVD in patients with CKD.
Source: Clinical and Experimental Nephrology - July 19, 2015 Category: Urology & Nephrology Source Type: research